C - Chemistry – Metallurgy – 07 – K
Patent
C - Chemistry, Metallurgy
07
K
C07K 16/24 (2006.01) A61P 37/06 (2006.01)
Patent
CA 2678626
The invention relates to fully human antibodies, and fragments thereof, that bind to interferon-inducible-protein-10 (IP-IO, CXCLlO), thereby modulating the interaction between IP-IO and its receptor, CXCR3, and/or modulating the biological activities of IP-IO. The invention also relates to the use of such anti-IP- 10 antibodies in the prevention or treatment of immune-related disorders and in the amelioration of one or more symptoms associated with an immune-related disorder.
L'invention concerne des anticorps totalement humains et des fragments de ceux-ci, qui se lient à la protéine 10 inductible par un interféron (IP-I0, CXCL10), modulant ainsi l'interaction entre IP-I0 et son récepteur, CXCR3 et/ou modulant les activités biologiques de IP-IO). L'invention concerne également l'utilisation de tels anticorps anti-IP10 dans la prévention ou le traitement de troubles de nature immunitaire et dans l'amélioration d'un ou plusieurs symptômes associés à un trouble de nature immunitaire.
Fischer Nicolas
Kosco-Vilbois Marie
Leger Olivier
Novimmune S.a.
Ridout & Maybee Llp
LandOfFree
Anti-ip-10 antibodies and methods of use thereof does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Anti-ip-10 antibodies and methods of use thereof, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Anti-ip-10 antibodies and methods of use thereof will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1963199